Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
- PMID: 34098210
- PMCID: PMC8630075
- DOI: 10.1016/j.jsat.2021.108514
Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms
Abstract
Objective: The COVID-19 pandemic led to unprecedented temporary federal and state regulatory flexibilities that rapidly transformed medication for opioid use disorder (MOUD) treatment delivery. This study aimed to understand changes in treatment providers' care during COVID-19, provider experiences with the adaptations, and perceptions of which changes should be sustained long-term.
Methods: We conducted in-depth, semi-structured interviews with 20 New Jersey MOUD providers, purposively sampled to reflect diversity in provider setting, specialty, and other characteristics. Using a rapid analysis approach, we summarized content within interview domains and analyzed domains across participants for recurring concepts and themes.
Results: MOUD treatment practice changes taking place during the COVID-19 pandemic included a rapid shift from in-person care to telehealth, reduction in frequency of toxicology testing and psychosocial/counseling services, and modifications to prescription durations and take-home methadone supplies. Modifications to practice were positively received and reinforced a sense of autonomy for providers as well as enhancing the ability to provide patient-centered care. All respondents expressed support for making temporary regulatory flexibilities permanent, but differed in their implementation of the flexibilities and the extent to which they planned to modify their own practices long-term.
Conclusion: Findings support sustaining temporary regulatory and payment changes to MOUD practice, which may have improved treatment access and allowed for more flexible, individually tailored patient care. Few negative, unintended consequences were reported by providers, but more research is needed to evaluate the patient experience with changes to practice during the COVID-19 pandemic.
Keywords: Buprenorphine; COVID-19; Medication for addiction treatment; Medication for opioid use disorder; Methadone; Telehealth.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
None.
Similar articles
-
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID.PLoS One. 2022 Oct 25;17(10):e0274094. doi: 10.1371/journal.pone.0274094. eCollection 2022. PLoS One. 2022. PMID: 36282806 Free PMC article.
-
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?J Subst Abuse Treat. 2021 Mar;122:108196. doi: 10.1016/j.jsat.2020.108196. Epub 2020 Nov 14. J Subst Abuse Treat. 2021. PMID: 33221125 Free PMC article.
-
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284. JAMA Psychiatry. 2022. PMID: 36044198 Free PMC article.
-
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.Addict Sci Clin Pract. 2021 Nov 13;16(1):68. doi: 10.1186/s13722-021-00275-1. Addict Sci Clin Pract. 2021. PMID: 34774106 Free PMC article.
-
Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy.Lancet Public Health. 2023 Mar;8(3):e238-e246. doi: 10.1016/S2468-2667(23)00023-3. Lancet Public Health. 2023. PMID: 36841564 Free PMC article. Review.
Cited by
-
Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore.J Subst Use Addict Treat. 2023 Feb;145:208946. doi: 10.1016/j.josat.2022.208946. Epub 2023 Jan 7. J Subst Use Addict Treat. 2023. PMID: 36880915 Free PMC article.
-
Perceived Barriers and Facilitators of Behavioral-Health Modality Change Adoption During the COVID-19 Pandemic: A Systematic Review.J Multidiscip Healthc. 2024 Dec 3;17:5695-5713. doi: 10.2147/JMDH.S472060. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39649371 Free PMC article. Review.
-
Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19.AJPM Focus. 2023 Dec 24;3(2):100177. doi: 10.1016/j.focus.2023.100177. eCollection 2024 Apr. AJPM Focus. 2023. PMID: 38312524 Free PMC article.
-
North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic.J Addict Med. 2024 Mar-Apr 01;18(2):e1-e7. doi: 10.1097/ADM.0000000000001272. Epub 2024 Feb 9. J Addict Med. 2024. PMID: 38345239 Free PMC article.
-
Methadone treatment utilization and overdose trends among Medicaid beneficiaries in New Jersey before and during the COVID-19 pandemic.J Subst Use Addict Treat. 2024 Dec;167:209476. doi: 10.1016/j.josat.2024.209476. Epub 2024 Aug 7. J Subst Use Addict Treat. 2024. PMID: 39097192 Free PMC article.
References
-
- Bean M. Becker’s hospital review. 2020. COVID-19 death rates by state: Dec. 18.https://www.beckershospitalreview.com/public-health/us-coronavirus-death... Retrieved December 18, 2020, from.
-
- Carlson R.G., Daniulaityte R., Silverstein S.M., Nahhas R.W., Martins S.S. Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose? The International Journal on Drug Policy. 2020;79:102722. doi: 10.1016/j.drugpo.2020.102722. - DOI - PMC - PubMed
-
- Center for Connected Health Policy Telehealth coverage policies in the time of COVID-19. 2020. https://www.cchpca.org/resources/covid-19-telehealth-coverage-policies Retrieved December 22, 2020, from.
-
- Center on Budget and Policy Priorities Tracking the COVID-19 recession's effects on food, housing, and employment hardships. 2020, December 16. https://www.cbpp.org/research/poverty-and-inequality/tracking-the-covid-... Retrieved December 18, 2020, from.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical